Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects*; D003517:Cyclopentanes / Q000009:adverse effects / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D005082:Physical Exertion; D011412:Propanolamines / Q000009:adverse effects / Q000494:pharmacology*; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D003517:Cyclopentanes; D011412:Propanolamines